Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA

Cholesterol acyltransferase activity in human liver

Nicola Abate, F. Carubbi, M. Bozzoli, M. Bertolotti, I. Farah, A. Rosi, N. Carulli

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In order to investigate the relationship between bile acid pool composition and hepatic cholesterol metabolism in humans, we studied the effect of chronic feeding of chenodeoxycholic (CDCA) or ursdeoxycholic acid (UDCA) on the hepatic activity of acyl-CoA: cholesterol acyltransferase (ACAT) evaluated 'in vitro'. Twenty-eight gallstone patients were admitted to the study: 15 were untreated subjects, 8 were treated with UDCA (10 mg/kg/day for 15-20 days) and 5 were treated with CDCA (15 mg/kg/day for 15-20 days). A liver specimen and a bile sample were obtained during laparotomy for elective cholecystectomy. Untreated subjects had bile supersaturated with cholesterol (mean saturation index: 1.35 ± 0.31) whereas subjects treated with either UDCA or CDCA had bile unsaturated with cholesterol (mean saturation index: 0.66 ± 0.1 and 0.75 ± 0.06 respectively). In all treated subjects the bile acid administered became predominant in bile. ACAT activity was 14% lower in subjects treated with UDCA and 16% lower in those treated with CDCA compared to controls; the differences did not achieve statistical significance. Microsomal cholesterol content did not differ between the groups (75.4 ± 7.2 nmol/mg protein in control group; 86.5 ± 7.0 nmol/mg protein in CDCA treated group; 83.4 ± 70 nmol/mg protein in UDCA treated group). Our data show that the cholesterol esterifying activity of human liver is not affected by changes in bile acid pool composition.

Original languageEnglish (US)
Pages (from-to)287-293
Number of pages7
JournalItalian Journal of Gastroenterology
Volume26
Issue number6
StatePublished - 1994
Externally publishedYes

Fingerprint

Sterol O-Acyltransferase
Chenodeoxycholic Acid
Ursodeoxycholic Acid
Human Activities
Bile
Cholesterol
Bile Acids and Salts
Acids
Liver
Proteins
Cholecystectomy
Gallstones
Laparotomy
Control Groups

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Abate, N., Carubbi, F., Bozzoli, M., Bertolotti, M., Farah, I., Rosi, A., & Carulli, N. (1994). Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: Cholesterol acyltransferase activity in human liver. Italian Journal of Gastroenterology, 26(6), 287-293.

Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA : Cholesterol acyltransferase activity in human liver. / Abate, Nicola; Carubbi, F.; Bozzoli, M.; Bertolotti, M.; Farah, I.; Rosi, A.; Carulli, N.

In: Italian Journal of Gastroenterology, Vol. 26, No. 6, 1994, p. 287-293.

Research output: Contribution to journalArticle

Abate, N, Carubbi, F, Bozzoli, M, Bertolotti, M, Farah, I, Rosi, A & Carulli, N 1994, 'Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: Cholesterol acyltransferase activity in human liver', Italian Journal of Gastroenterology, vol. 26, no. 6, pp. 287-293.
Abate, Nicola ; Carubbi, F. ; Bozzoli, M. ; Bertolotti, M. ; Farah, I. ; Rosi, A. ; Carulli, N. / Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA : Cholesterol acyltransferase activity in human liver. In: Italian Journal of Gastroenterology. 1994 ; Vol. 26, No. 6. pp. 287-293.
@article{ba398f2490dc4ed8a18e038670e4606b,
title = "Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: Cholesterol acyltransferase activity in human liver",
abstract = "In order to investigate the relationship between bile acid pool composition and hepatic cholesterol metabolism in humans, we studied the effect of chronic feeding of chenodeoxycholic (CDCA) or ursdeoxycholic acid (UDCA) on the hepatic activity of acyl-CoA: cholesterol acyltransferase (ACAT) evaluated 'in vitro'. Twenty-eight gallstone patients were admitted to the study: 15 were untreated subjects, 8 were treated with UDCA (10 mg/kg/day for 15-20 days) and 5 were treated with CDCA (15 mg/kg/day for 15-20 days). A liver specimen and a bile sample were obtained during laparotomy for elective cholecystectomy. Untreated subjects had bile supersaturated with cholesterol (mean saturation index: 1.35 ± 0.31) whereas subjects treated with either UDCA or CDCA had bile unsaturated with cholesterol (mean saturation index: 0.66 ± 0.1 and 0.75 ± 0.06 respectively). In all treated subjects the bile acid administered became predominant in bile. ACAT activity was 14{\%} lower in subjects treated with UDCA and 16{\%} lower in those treated with CDCA compared to controls; the differences did not achieve statistical significance. Microsomal cholesterol content did not differ between the groups (75.4 ± 7.2 nmol/mg protein in control group; 86.5 ± 7.0 nmol/mg protein in CDCA treated group; 83.4 ± 70 nmol/mg protein in UDCA treated group). Our data show that the cholesterol esterifying activity of human liver is not affected by changes in bile acid pool composition.",
author = "Nicola Abate and F. Carubbi and M. Bozzoli and M. Bertolotti and I. Farah and A. Rosi and N. Carulli",
year = "1994",
language = "English (US)",
volume = "26",
pages = "287--293",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA

T2 - Cholesterol acyltransferase activity in human liver

AU - Abate, Nicola

AU - Carubbi, F.

AU - Bozzoli, M.

AU - Bertolotti, M.

AU - Farah, I.

AU - Rosi, A.

AU - Carulli, N.

PY - 1994

Y1 - 1994

N2 - In order to investigate the relationship between bile acid pool composition and hepatic cholesterol metabolism in humans, we studied the effect of chronic feeding of chenodeoxycholic (CDCA) or ursdeoxycholic acid (UDCA) on the hepatic activity of acyl-CoA: cholesterol acyltransferase (ACAT) evaluated 'in vitro'. Twenty-eight gallstone patients were admitted to the study: 15 were untreated subjects, 8 were treated with UDCA (10 mg/kg/day for 15-20 days) and 5 were treated with CDCA (15 mg/kg/day for 15-20 days). A liver specimen and a bile sample were obtained during laparotomy for elective cholecystectomy. Untreated subjects had bile supersaturated with cholesterol (mean saturation index: 1.35 ± 0.31) whereas subjects treated with either UDCA or CDCA had bile unsaturated with cholesterol (mean saturation index: 0.66 ± 0.1 and 0.75 ± 0.06 respectively). In all treated subjects the bile acid administered became predominant in bile. ACAT activity was 14% lower in subjects treated with UDCA and 16% lower in those treated with CDCA compared to controls; the differences did not achieve statistical significance. Microsomal cholesterol content did not differ between the groups (75.4 ± 7.2 nmol/mg protein in control group; 86.5 ± 7.0 nmol/mg protein in CDCA treated group; 83.4 ± 70 nmol/mg protein in UDCA treated group). Our data show that the cholesterol esterifying activity of human liver is not affected by changes in bile acid pool composition.

AB - In order to investigate the relationship between bile acid pool composition and hepatic cholesterol metabolism in humans, we studied the effect of chronic feeding of chenodeoxycholic (CDCA) or ursdeoxycholic acid (UDCA) on the hepatic activity of acyl-CoA: cholesterol acyltransferase (ACAT) evaluated 'in vitro'. Twenty-eight gallstone patients were admitted to the study: 15 were untreated subjects, 8 were treated with UDCA (10 mg/kg/day for 15-20 days) and 5 were treated with CDCA (15 mg/kg/day for 15-20 days). A liver specimen and a bile sample were obtained during laparotomy for elective cholecystectomy. Untreated subjects had bile supersaturated with cholesterol (mean saturation index: 1.35 ± 0.31) whereas subjects treated with either UDCA or CDCA had bile unsaturated with cholesterol (mean saturation index: 0.66 ± 0.1 and 0.75 ± 0.06 respectively). In all treated subjects the bile acid administered became predominant in bile. ACAT activity was 14% lower in subjects treated with UDCA and 16% lower in those treated with CDCA compared to controls; the differences did not achieve statistical significance. Microsomal cholesterol content did not differ between the groups (75.4 ± 7.2 nmol/mg protein in control group; 86.5 ± 7.0 nmol/mg protein in CDCA treated group; 83.4 ± 70 nmol/mg protein in UDCA treated group). Our data show that the cholesterol esterifying activity of human liver is not affected by changes in bile acid pool composition.

UR - http://www.scopus.com/inward/record.url?scp=0027937376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027937376&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 287

EP - 293

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 6

ER -